Updated as of February 13, 2023 It is based on the local time of Seoul, Korea. (UTC+9)

• Thursday, June 15
• Friday, June 16

Date & Time	6/15(Thu) 11:00-11:40	Room	Crystal Ballroom (2F)
Targeting tumor-infiltrating Tregs as a cancer immunotherapy Shimon Sakaguchi (Immunology Frontier Research Center, Osaka University, Japan)

Date & Time	6/15(Thu) 11:40-12:20	Room	Crystal Ballroom (2F)
The seven deadly hallmarks of pancreatic cancer David Tuveson (Cold Spring Harbor Laboratory Cancer Center, USA)

Session Title	Single-cell multiomics
Date & Time	6/15(Thu) 09:00-10:40	Room	Crystal Ballroom A (2F)
1) scMultiomics (RNA + ATAC) for acquired epithelial WNT secretion drives niche independence of developing gastric cancer Heetak Lee (Institute for Basic Science)
2) Spatial transcriptome analysis for tumor microenvironment Woong-Yang Park (Samsung Genome Institute)
3) Spatial analysis of microbiome and host transcriptomics/epitranscriptomics in tumor tissue and circulating tumor cells of triple negative breast cancer patients: A novel approach to drug discovery Amos Chungwon Lee (Seoul National University College of Engineering)
4) Single cell genomics approach to identify immune determinants for PD-1 inhibitors Hye Ryun Kim (Yonsei University College of Medicine)

Session Title	Population science and early cancer detection
Date & Time	6/15(Thu) 09:00-10:40	Room	Crystal Ballroom B (2F)
1) Current status of cancer burden in Korea Kyu Won Jung (National Cancer Center)
2) Genetic and environmental determinants for cancer and the role of early detection Aesun Shin (Seoul National University College of Medicine)
3) Harnessing multimodal cancer signatures in circulating tumor DNA for earlier cancer detection Duhee Bang (Yonsei University College of Science)

Session Title	Liquid biopsy and extracelluar vesicles
Date & Time	6/15(Thu) 09:00-10:40	Room	Sapphire Ballroom A (3F)
1) Clinical implimentation of liquid biopsy in genitourinary cancers Nobuaki Matsubara (National Cancer Center Hospital East, Japan)
2) Monitoring and prediction for clinical outcomes after irradiation Jae Myoung Noh (Sungkyunkwan University School of Medicine)
3) Disease evaluation or monitoring using extracellualr vesicle Han Sang Kim (Yonsei University College of Medicine)

Session Title	Engineering antibody and drug conjugates for cancer therapy
Date & Time	6/15(Thu) 13:20-15:00	Room	Crystal Ballroom A (2F)
1) Antibody discovery and engineering: Past, present and future Chang-Han Lee (Seoul National University)
2) Antibody-drug conjugates in clinical practice: Recent advances and future directions Chul Kim (Georgetown Lombardi Comprehensive Cancer Center, USA)
3) Resistance to antibody-drug conjugates Chul-Woong Chung (Legochem Biosciences)
4) Antibody-drug conjugate (ADC) targeting claudin 18.2 prepared by site-selective antibody conjugation linker Sang Jeon Chung (Sungkyunkwan University School of Pharmacy)

Session Title	Novel cellular and gene-editing therapies
Date & Time	6/15(Thu) 15:20-17:00	Room	Sapphire Ballroom A (3F)
1) Recent advances in CAR-T cell engineering for solid tumors Chungyong Han (National Cancer Center)
2) Current status of CAR-T cell therapy trials for lymphoma in Korea Dok Hyun Yoon (University of Ulsan College of Medicine)
3) Nanomedicine approaches for in vivo gene editing and therapy Hyun Jung Chung (Korea Advanced Institute of Science and Technology)
4) Platform development for CAR-NK therapy: Gene design and delivery Tae-Don Kim (Korea Research Institute of Bioscience and Biotechnology)

Session Title	Cutting-edge technologies for immunotherapy
Date & Time	6/15(Thu) 13:20-15:00	Place	Crystal Ballroom B (2F)
1) TIME-controlled cancer immunotherapy Yong Taik Lim (Sungkyunkwan University College of Engineering)
2) Novel technologies of CAR-T cell therapy for solid cancers Koji Tamada (Yamaguchi University, Japan)
3) Harnessing anti-viral CD8+ T cells to kill tumor cells for cancer immunotherapy Yong-Sung Kim (Ajou University College of Engineering )
4) Treg activation mechanisms in tumor microenvironment and application to immunotherapy Shohei Koyama (National Cancer Center, Japan)

Session Title	Updates on oligometastasis
Date & Time	6/15(Thu) 13:20-15:00	Place	Sapphire Ballroom A (3F)
1) Updates on radiotherapy for oligometastatic and oligoprogressive cancer C. Jillian Tsai (Princess Margaret Cancer Centre, University Health Network, Canada)
2) Customized RT in oligometastasis Won Kyung Cho (Samsung Medical Center)
3) Update on surgical management for oligometastasis Jun Won Um (Korea University College of Medicine)
4) Issues of care for oligometastasis in clinical practice Myung-Ah Lee (The Catholic University of Korea College of Medicine)
5) Barriers in oligometastasis care, an RO perspective Eui Kyu Chie (Seoul National University College of Medicine)

Session Title	Overcome resistance to immunotherapy
Date & Time	6/15(Thu) 15:20-17:00	Place	Crystal Ballroom A (2F)
1) NANOG is a main driver of therapy-refractory evolution of tumor cells during immunotherapy Tae Woo Kim (Korea University College of Medicine)
2) Elucidation of sensitivity and resistance factors to cancer immunotherapy using artificial intelligence Se-Hoon Lee (Sungkyunkwan University School of Medicine)
3) Blood-derived tumor-associated macrophages contribute to antitumor immunity against glioblastoma Heung Kyu Lee (Korea Advanced Institute of Science and Technology)
4) Tumor hypoxia as a target for immunotherapy Kyong Hwa Park (Korea University College of Medicine)

Session Title	Understanding tumor ecosystems
Date & Time	6/15(Thu) 15:20-17:00	Place	Crystal Ballroom B (2F)
1) Single-cell analysis reveals recurring programs in cancer microenvironment Jong-Eun Park (Korea Advanced Institute of Science and Technology)
2) Stromal reprogramming boosts the efficacy of anti-PD-1 immunotherapy in fibrotic tumors Takatsugu Ishimoto (Kumamoto University, Japan)
3) A TEAD2-driven endothelial program controls basal-like differentiation and metastasis of pancreatic cancer Jae-Seok Roe (Yonsei University College of Life Science & Biotechnology)
4) Resolving transcriptional dynamics for single cell and spatial transcriptomics of gastric cancers Tae-Min Kim (The Catholic University of Korea College of Medicine)

Session Title	암 정보 현황과 정책 방향
Date & Time	6/15(Thu) 15:20-17:00	Place	Sapphire Ballroom B (3F)
1) 한국 보건의료정보 발전방향 변남수 (한국보건의료정보원)
2) 암데이터 구축과 활용체계: 암 임상네트워크 구축사업(K-CURE)을 중심으로 최귀선 (국립암센터 암빅데이터센터)
3) 보건의료연구자원 선순환체계 구축과 활용 박현영 (질병관리청 미래연구부)
4) 국가바이오데이터스테이션 소개 김선영 (한국생명공학연구원)

Date & Time	6/15(Thu) 12:20-13:00	Place	Crystal Ballroom A (2F)
Blossom women's more TOMMOROWs with pembrolizumab Gun Min Kim (Yonsei University College of Medicine)

Date & Time	6/15(Thu) 12:20-12:40	Place	Crystal Ballroom B (2F)
Illuminating the path forward in early stage NSCLC: Unmet needs and the evolving treatment landscape (IMP010) Sun Min Lim (Yonsei University College of Medicine)

Date & Time	6/15(Thu) 12:20-12:40	Place	Sapphire Ballroom A (3F)
Clinical considerations for ribociclib treatment in HR+HER2- mBC patients Hye Sung Won (The Catholic University of Korea College of Medicine)

Date & Time	6/15(Thu) 09:00-10:40	Place	Sapphire Ballroom B (3F)
1) A new plasmacytoid dendritic cell-based vaccine in combination with anti-PD-1 expands tumor-specific CD8+ T cells of lung cancer patients Joel Plumas (PDC*line Pharma, France)
2) Effects of multi-ion beam irradiation alone or in combination with KRAS G12C inhibitor sotorasib on lung cancer cells Sei Sai (Institute of Quantum Medical Science, National Institutes for Quantum Science and Technology, Japan)
3) Comprehensive profiling of mutational signatures and machine learning reveal subtypes of homologous recombination deficiency Joonoh Lim (Genome Insight Inc.)
4) Prognostic significance of immune-activated sentinel lymph node in patients with node-negative triple negative breast cancer Kabsoo Shin (Seoul St. Mary’s Hospital)
5) Multi-level knowledge graph neural network explains assays for breast cancer recurrence Joonhyeong Park (Seoul National University)

Date & Time	6/15(Thu) 13:20-15:00	Place	Sapphire Ballroom B (3F)
1) Clinical activity and dynamic immune correlates of clinical outcomes to nivolumab plus regorafenib in hepatocellular carcinoma: An integrated clinical and biomarker analysis of the phase 2 RENOBATE trial Hyung-Don Kim (Asan Medical Center, University of Ulsan College of Medicine)
2) Molecular subtypes from endoscopy ultrasound-guided biopsy samples at initial diagnosis predict therapeutic response for neoadjuvant chemotherapy in borderline resectable pancreatic cancer. Sung Hwan Lee (CHA University School of Medicine)
3) Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial Hyung-Don Kim (Asan Medical Center, University of Ulsan College of Medicine)
4) The microenvironment of normal mucosa could predict recurrence in the stage II/III colorectal cancer Yeong Hak Bang (Samsung Medical Center)
5) Conization before radical hysterectomy in early cervical cancer: A Korean multi-center study Se Ik Kim (Seoul National University College of Medicine)

Date & Time	6/15(Thu) 13:20-15:00	Place	Sapphire Ballroom C (3F)
1) Integrative analysis of epigenomic and transcriptomic profiling identifies EZH2 target genes associated with cysteine metabolism mediated ferroptosis in HCC. Jaehyun Lee (Chungbuk National University)
2) Small extracellular vesicles-GCC2 for the early diagnosis and therapeutic target of lung adenocarcinoma: A multicenter trial Byeong Hyeon Choi (Korea University Guro Hospital)
3) Intratumoral IL-12 delivery via mesenchymal stem cells combined with PD-1 blockade leads to long-term antitumor immunity in a mouse glioblastoma model Junseong Park (The Catholic University of Korea)
4) GPR143 controls exosome biogenesis and promotes cancer metastasis Yu Jin Lee (Ulsan National Institute of Science and Technology)
5) Deep learning-based diagnosis of lung cancer on cytopathological images from respiratory tract Taehee Kim (Hallym University Kangnam Sacred Heart Hospital)
6) Conditional relative survival of surgical gastric cancer patients: A hospital-based study Hyeree Park (Seoul National University College of Medicine)

Date & Time	6/16(Fri) 10:20-11:00	Room	Crystal Ballroom (2F)
Adjuvant treatment of resectable gastric cancer. Where are we now in Asia? Yoon-Koo Kang (University of Ulsan College of Medicine)

Date & Time	6/16(Fri) 11:00-11:40	Room	Crystal Ballroom (2F)
Mechanism of action and inflammatory axis for air pollution induced non-small cell lung cancer Charles Swanton (Francis Crick Institute & UCL Cancer Institute, UK)

Session Title	Practical consideration for perioperative treatment
Date & Time	6/16(Fri) 15:20-17:00	Room	Crystal Ballroom A (2F)
1) Design and interpretation of (Neo)adjuvant trials Juhee Cho (Sungkyunkwan University)
2) Pathologic assessments after neoadjuvant therapy Gyungyub Gong (University of Ulsan College of Medicine)
3) Pathologic complete response as an endpoint in cancer clinical trials Jee Hyun Kim (Seoul National University College of Medicine)
4) Practical consideration for perioperative treatment: Neoadjuvant vs. adjuvant chemoimmunotherapy Eun Joo Kang (Korea University College of Medicine)

Session Title	Spatial biology for cancer research
Date & Time	6/16(Fri) 15:20-17:00	Room	Crystal Ballroom A (2F)
1) Applying spatial transcriptomics and computational analyses to study cell-cell interactions and drug responses Quan Nguyen (The University of Queensland, Australia)
2) High-resolution spatial transcriptomic and epitranscriptomic mapping of cancer tissues using SLACS Sunghoon Kwon (Seoul National University College of Engineering)
3) Decoding cancer's complexity: Single-cell and spatial genomics meet machine learning and AI for personalized immunotherapy and cellular therapy Tae Hyun Hwang (Mayo Clinic, USA)
4) Spatial transcriptomics for clinical translation Kwon Joong Na (Seoul National University College of Medicine)

Session Title	Real-world clinico-genomic data
Date & Time	6/16(Fri) 09:00-10:00	Place	Crystal Ballroom A (2F)
1) The national Network Genomic Medicine (nNGM) lung cancer Jürgen Wolf (University Hospital of Cologne, Germany)
2) Leveraging genomic data into clinic, -or even clinical trials Sung Gwe Ahn (Gangnam Severance Hospital)
3) Prescribing genomic analyses in clinic, evidences and practical issues Sheehyun Kim (Seoul National University Hospital)

Session Title	Novel treatment for pediatric CNS tumors
Date & Time	6/16(Fri) 09:00-10:00	Place	Sapphire Ballroom A (3F)
1) Molecular pathology of pediatric CNS tumors Se Hoon Kim (Yonsei University College of Medicine)
2) Molecular targeted therapy for pediatric brain tumors Jung Yoon Choi (Seoul National University College of Medicine)
3) Precision drug discovery and clinical practice in rare cancer Do-Hyun Nam (Sungkyunkwan University School of Medicine)

Session Title	Cancer genomics
Date & Time	6/16(Fri) 13:20-15:00	Place	Crystal Ballroom A (2F)
1) Genomics approaches to identifying neoantigen vaccine and CAR therapy targets Jung Kyoon Choi (Korea Advanced Institute of Science and Technology)
2) Implications of cancer cell state plasticity for therapeutic intervention Wai Leong Tam (CSI Singapore & National University of Singapore, Singapore)
3) R-loop-induced phase separation provides the basis of Alternative Lengthening of Telomeres (ALT) upon BRCA2 abrogation Hyunsook Lee (Seoul National University College of Natural Sciences)
4) Widespread 3’UTR splicing promotes oncogene expression and tumorigenesis Yvonne Tay (CSI Singapore, National University of Singapore, Singapore)

Session Title	Increasing the therapeutic ratio of radiotherapy using biochemical combination
Date & Time	6/16(Fri) 13:20-15:00	Place	Crystal Ballroom B (2F)
1) Glioblastoma metabolism and radioresistance BuHyun Youn (Pusan National University)
2) Ceria-based nanoparticles for therapeutic antioxidants and radioprotectants Taeghwan Hyeon (Seoul National University College of Engineering)
3) Targeting PI3Kδ/γ as a novel immune-regulatory radiosensitizer Jae-Sung Kim (Korea Institute of Radiological & Medical Sciences)
4) Targeting SDC1-dependent TGM2 enhances radiosensitivity of glioblastoma by coordinating EPG5-mediated fusion of autophagosomes with lysosomes Chunlin Shao (Fudan University, China)

Session Title	Changing clinical practice in gynecologic cancer: Current status and future perspective
Date & Time	6/16(Fri) 13:20-15:00	Place	Sapphire Ballroom A (3F)
1) Changes in the tumor immune microenvironment during treatment in ovarian cancer Jung-Yun Lee (Yonsei University College of Medicine)
2) Immunotherapy related biomarker in gynecologic cancer Sook Hee Hong (The Catholic University of Korea College of Medicine)
3) Brachytherapy in cervical cancer Won Kyung Cho (Samsung Medical Center)
4) Recent update of the radiologic characterization and report of ovarian cancer Sung Il Hwang (Seoul National University Bundang Hospital)

Session Title	국립암센터 항암신약치료개발사업단 임상개발 현황
Date & Time	6/16(Fri) 13:20-15:00	Place	Sapphire Ballroom B (3F)
1) NOIU 국내 항암신약 개발 중요성 및 전망 김학균 (국립암센터)
2) Next generation PARP and TNKS inhibitor development 김정훈 (Onconic Therapeutics)
3) HPV therapeutic vaccine development for the treatment of recurrent/metastatic cervical cancer 우정원 (Genexine)
4) T cell agonist anti-4-BB in the clinical trial 이중원 (Eutilex)

Session Title	Current advance of multidisciplinary management in HCC
Date & Time	6/16(Fri) 15:20-17:00	Place	Sapphire Ballroom A (3F)
1) Multidisciplinary HCC management in China - experience of SYSUCC Dandan Hu (Sun Yat-Sen University Cancer Center, China)
2) Recent progress for early detection of HCC in chronic liver diseases Pil Soo Sung (The Catholic University of Korea College of Medicine)
3) Emerging neoadjuvant or conversion therapies Tianqiang Song (Tianjin Medical University Cancer Institute & Hospital, China)
4) Could we predict the response of immune checkpoint inhibitor treatment in hepatocellular carcinoma? Hong Jae Chon (CHA University School of Medicine)

Session Title	암관련학회협의체 심포지엄: 암정밀의료에서 NGS의 역할
Date & Time	6/16(Fri) 15:20-17:00	Place	Sapphire Ballroom B (3F)
1) 암정밀의학에서 NGS 임상 적용의 글로벌 현황 윤신교 (울산의대)
2) 암 진단 및 치료 과정에서 유전체 프로파일링의 역할 및 미래 (의약업계 전망) 김승은 (노바티스)
3) 국내 NGS 기반 암정밀의료 연구 플랫폼 - KOSMOS II 김선영 (서울아산병원)
4) 국내 NGS 현황 및 정책추진 방향 이승용 (식품의약품안전처)
5) 패널 토론 윤신교 (울산의대), 김승은 (노바티스), 김선영 (서울아산병원), 이승용 (식품의약품안전처), 배정모 (서울의대)

Session Title	Special Lecture
Date & Time	6/16(Fri) 09:30-10:00	Place	Sapphire Ballroom B (3F)
Next-generation approaches to discovering therapeutics and therapeutic targets in cancer William R. Sellers (Broad Institute, USA)

Session Title	Young Investigator Symposium
Date & Time	6/16(Fri) 09:00-10:10	Place	Crystal Ballroom B (2F)
1) A mechanism of oncogene amplification in breast cancer June-Koo Lee (Memorial Sloan-Kettering Cancer Center, USA)
2) Cancer prevention Jung Yong Hong (Sungkyunkwan University College of Medicine)
3) Unraveling the role of neural stem cells in glioblastoma and targeting tumor-initiating cells to prevent recurrence Joo Ho Lee (Seoul National University College of Medicine)

Date & Time	6/16(Fri) 11:40-12:20	Place	Crystal Ballroom A (2F)
New approaches for treatment of small cell lung cancer Beung-Chul Ahn (National Cancer Center)

Date & Time	6/16(Fri) 11:40-12:00	Place	Crystal Ballroom B (2F)
IO in GC/GEJ/EAC 1L with 3y long-term data Woo Kyun Bae (Chonnam National University Medical School)

Date & Time	6/16(Fri) 11:40-12:00	Place	Sapphire Ballroom A (3F)
Take hope further for HR+HER2- high-risk early breast cancer patients with abemiciclib Keun Seok Lee (National Cancer Center)

Date & Time	6/16(Fri) 13:20-15:00	Place	Sapphire Ballroom C (3F)
1) Developing new prognostic scores through DNA methylation array-based single-sample inference of 3D genome states Jeewon Yang (Interdisciplinary Program in Artificial Intelligence, Seoul National University)
2) Targeting a Treg-specific deubiquitinase module for antitumor immune therapy Deyu Fang (Northwestern University Feinberg School of Medicine, USA)
3) TET loss-of-function in hematologic neoplasia Myunggon Ko (Ulsan National Institute of Science and Technology)
4) Age-specific variations in the risk of subsequent primary cancer among Korean survivors of adult-onset cancers Yoon Young Choi (SoonChunHyang University Bucheon Hospital)
5) A phase 1 study of AT101, a novel anti-CD19 CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine)